Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis

Table 3

Demographics and clinical characteristics of effective and ineffective group 1 year post-SLIT.

Variables	Effective group ()	Ineffective group ()	value
Sex			0.077
Male	22 (40.0%)	26 (57.8%)
Female	33 (60.0%)	19 (42.2%)
Age, years			0.627
BMI, kg/m^2			0.771
Smoking, yes/no	26/29	24/21	0.546
Drinking, yes/no	26/29	19/26	0.614
Baseline VAS			0.027
Baseline TNSS			0.202

BMI: body mass index; VAS: visual analogue scales; TNSS: total nasal symptoms score; SLIT: sublingual immunotherapy.